HOME >> BIOLOGY >> NEWS
Holographic movies show promise for medical, military applications

DALLAS June 14, 2005 In a small research laboratory at UT Southwestern Medical Center, a grainy, red movie of circling fighter jets emerges from a table-top black box, while nearby, a video of a rotating human heart hangs suspended in a tank of gooey gel.

These images the first true, three-dimensional, holographic movies are the brainchild of Dr. Harold "Skip" Garner, professor of biochemistry and internal medicine at UT Southwestern.

While such movies will not be coming soon to a theater near you, they have earned Dr. Garner and his "holographic television" a spot on Popular Science magazine's list of the top five "great ideas for the future," featured in the June 2005 issue.

"I thought it was great that we made this list," Dr. Garner said. "It's good company to be in."

Also on the Popular Science list are a bionic eye, technology for a "smart" home, a tourist's spacesuit and the ultimate roller coaster.

"An important next step is to take our proof of principle technology that we have now and move it into a commercial entity," said Dr. Garner. "We think the two initial markets will be in medical visualization and military applications, such as heads-up displays for helmets and military aircraft and coordinating battlefield information."

In the long term, Dr. Garner said, entertainment uses could include 3-D multiplayer games, theme park or advertising displays, and "Holo TV." He and his colleagues have worked with students in Southern Methodist University's Cox School of Business to develop a tentative business plan that explores the possible commercialization of the technology, focusing on medical applications.

"I predict that by the year 2020, that being the year of 'perfect vision,' we will have Holo TV in our homes," said Dr. Michael Huebschman, a postdoctoral researcher in Dr. Garner's lab and one of the developers of the technology.

Dr. Garner's holographic video system is based on complex optics principles, s
'"/>

Contact: Amanda Siegfried
amanda.siegfried@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
14-Jun-2005


Page: 1 2 3

Related biology news :

1. Coma misrepresented in movies
2. Time-lapse movies show brain cells move like a two-stroke engine
3. Insulin grown in plants relieves diabetes in mice; UCF study holds promise for humans
4. Radiation therapy combined with microsurgery shows promise for curing injured spinal cord
5. New proteomics research promises to revolutionize biomedical discovery
6. New research holds promise for protecting cancer patients against infertility
7. New approach to pulmonary hypertension shows promise
8. Modular leukemia drug shows promise in early testing
9. Hepatitis B drug can compromise HIV treatment
10. UCF nanoparticle offers promise for treating glaucoma
11. Identification of genetic risk factor for coeliac disease promises improved treatment

Post Your Comments:
(Date:5/21/2013)... Researchers at USC have found that a class of ... mice. , The drugs, known as "TSPO ligands," ... "We looked at the effects of TSPO ligand in ... stage, and in aged mice when pathology was quite ... Davis School of Gerontology. "TSPO ligand reduced measures of ...
(Date:5/21/2013)... Researchers at the University of Illinois at Chicago College of ... and stores fat -- its main energy source -- and ... disease, under a new $2 million, 4-year grant from the ... heart changes how it uses fuel for energy. These changes ... disease and are different in men and women, says E. ...
(Date:5/21/2013)... charted the path of insulin action in cells in ... blueprint for understanding what goes wrong in diabetes. ... Professor David James from Sydney,s Garvan Institute of Medical ... of the prestigious journal Cell Metabolism . , ... very important role in the body because it helps ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2Do men's and women's hearts burn fuel differently? 2Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3
(Date:5/21/2013)... Alpha Source, Inc., a Wisconsin-based ... exhibiting for the 13th consecutive year at the ... 2013 Conference and Expo. The conference brings together ... healthcare technologies. This year’s event will be held ... , The three-day event draws over 1,500 healthcare ...
(Date:5/21/2013)... New York , May 21, 2013 ... by Transparency Market Research ( http://www.transparencymarketresearch.com ) "Biochip Products ... Research, IVD Tests) - U.S. Industry Analysis, Size, Share, Growth, ... 2.4 billion in 2011 and is expected to grow ... to reach an estimated value of USD 4.7 billion ...
(Date:5/21/2013)... 21, 2013  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... serious infectious diseases, announced today that Jeffrey Riley ... Annual Marcum LLP MicroCap Conference on Thursday, May 30, 2013 ... Grand Hyatt Hotel. Mr. Riley is scheduled to present at ... Synthetic Biologics, presentation can be accessed by logging onto the ...
(Date:5/21/2013)... Inflamax scientists worked closely with ... design the study, which will provide critical insight ... used in the study of allergy treatments, the ... (NAC) models. Although both the models are well ... no direct comparison between the allergic responses evoked ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2
Cached News: